Total Valuation
Lavipharm S.A. has a market cap or net worth of €271.54M. The enterprise value is €157.29.
Market Cap€271.54M
Enterprise Value€157.29
Share Statistics
Lavipharm S.A. has 170,778,490 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding170,778,490
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lavipharm S.A.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 5.11%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.11%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee219.59K
Profits Per Employee17.71K
Employee Count285
Asset Turnover0.48
Inventory Turnover1.46
Valuation Ratios
The current PE Ratio of Lavipharm S.A. is 44.8. Lavipharm S.A.’s PEG ratio is ―.
PE Ratio44.8
PS Ratio0.00
PB Ratio0.00
Price to Fair Value2.91
Price to FCF0.00
Price to Operating Cash Flow39.96
PEG Ratio―
Income Statement
In the last 12 months, Lavipharm S.A. had revenue of 62.58M and earned 5.99M in profits. Earnings per share was 0.04.
Revenue62.58M
Gross Profit28.80M
Operating Income7.16M
Pretax Income7.50M
Net Income5.99M
EBITDA12.38M
Earnings Per Share (EPS)0.04
Cash Flow
In the last 12 months, operating cash flow was 6.72M and capital expenditures -4.62M, giving a free cash flow of 2.10M billion.
Operating Cash Flow6.72M
Free Cash Flow2.10M
Free Cash Flow per Share0.01
Dividends & Yields
Lavipharm S.A. pays an annual dividend of €0.019, resulting in a dividend yield of 1.28%
Dividend Per Share€0.019
Dividend Yield1.28%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change116.02%
50-Day Moving Average1.46
200-Day Moving Average1.14
Relative Strength Index (RSI)42.72
Average Volume (3m)0.00
Important Dates
Lavipharm S.A. upcoming earnings date is Nov 17, 2025, TBA (Confirmed).
Last Earnings DateSep 18, 2025
Next Earnings DateNov 17, 2025
Ex-Dividend Date―
Financial Position
Lavipharm S.A. as a current ratio of 1.21, with Debt / Equity ratio of 50.28%
Current Ratio1.21
Quick Ratio0.68
Debt to Market Cap0.11
Net Debt to EBITDA1.80
Interest Coverage Ratio3.89
Taxes
In the past 12 months, Lavipharm S.A. has paid 2.45M in taxes.
Income Tax2.45M
Effective Tax Rate0.33
Enterprise Valuation
Lavipharm S.A. EV to EBITDA ratio is 15.06, with an EV/FCF ratio of 88.67.
EV to Sales2.98
EV to EBITDA15.06
EV to Free Cash Flow88.67
EV to Operating Cash Flow27.73
Balance Sheet
Lavipharm S.A. has €6.11M in cash and marketable securities with €28.14M in debt, giving a net cash position of -€22.26M billion.
Cash & Marketable Securities€6.11M
Total Debt€28.14M
Net Cash-€22.26M
Net Cash Per Share-€0.13
Tangible Book Value Per Share€0.04
Margins
Gross margin is 47.05%, with operating margin of 11.44%, and net profit margin of 9.57%.
Gross Margin47.05%
Operating Margin11.44%
Pretax Margin11.99%
Net Profit Margin9.57%
EBITDA Margin19.77%
EBIT Margin11.44%
Analyst Forecast
The average price target for Lavipharm S.A. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast18.20%
EPS Growth Forecast-33.83%